Bulletin
Investor Alert

New York Markets Open in:

CRISPR Therapeutics AG

NAS: CRSP

GO
/marketstate/country/us

Before the Bell

/zigman2/quotes/201181046/composite

$

79.56

Change

+0.15 +0.19%

Volume

Volume 916

Dec 9, 2021, 6:15 a.m.

Real time quotes

/zigman2/quotes/201181046/composite

Previous close

$ 79.41

$ 79.41

Change

+1.02 +1.30%

Day low

Day high

$75.69

$81.21

Open
Open: 78.39

52 week low

52 week high

$67.15

$220.20

Open

Market cap

$6.00B

Average volume

1.60M

P/E ratio

16.68

Rev. per Employee

$1,754

EPS

4.76

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/crsp

MarketWatch News on CRSP

  1. 4 Beaten-Down Biotech Stocks That Could Take Off

    3:07 p.m. Nov. 17, 2021

    - Barron's Online

  2. Beam Gets FDA Nod for First Gene-Editing Trial

    8:10 a.m. Nov. 9, 2021

    - Barron's Online

  3. Prime Is the Newest Gene Editing, and It's Getting Better

    6:11 p.m. Oct. 20, 2021

    - Barron's Online

  4. Crispr Therapeutics stock price target cut to $101 from $139 at Stifel Nicolaus

    5:44 a.m. Oct. 13, 2021

    - Tomi Kilgore

  5. This Fund Is Winning Big by Betting on Stocks That Help Humanity

    6:37 a.m. Sept. 27, 2021

    - Barron's Online

  6. Intellia Stock Is Rocketing Because of a Gene-Editing Breakthrough

    8:21 a.m. June 30, 2021

    - Barron's Online

  7. First In-Vivo Gene Editing Data Look Good for Intellia

    7:40 a.m. June 28, 2021

    - Barron's Online

  8. Vertex Shares Fall as Drug Fails. Analysts Say It's Time to Buy.

    7:37 a.m. June 11, 2021

    - Barron's Online

  9. How a Cloud Is Lifting from Bluebird and Other Gene Therapy Stocks

    12:38 p.m. June 7, 2021

    - Barron's Online

  10. 5 Undervalued Stocks in Biopharma, the Sweet Spot in Healthcare

    4:40 p.m. April 21, 2021

    - Barron's Online

  11. Crispr Therapeutics Is Upgraded After $900 Million Deal

    9:33 p.m. April 21, 2021

    - Barron's Online

  12. Biotech stocks are a buy — especially these 18 picks

    1:02 p.m. March 13, 2021

    - Michael Brush

  13. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/crsp

Other News on CRSP

  1. 3 Beaten-Down Biotech Stocks -- Are They Bargains Now?

    5:57 a.m. Dec. 8, 2021

    - Motley Fool

  2. Intellia and gene editing rivals rally from recent slump

    3:02 p.m. Dec. 7, 2021

    - Seeking Alpha

  3. Why CRISPR Therapeutics Stock Sank 12.5% in November

    7:30 p.m. Dec. 5, 2021

    - Motley Fool

  4. Is Vertex Pharmaceuticals Stock a Buy Now?

    5:25 a.m. Dec. 4, 2021

    - Motley Fool

  5. Will This Beaten-Down Stock Bounce Back? 3 Things to Know

    6:00 a.m. Nov. 29, 2021

    - Motley Fool

  6. CRISPR Therapeutics (CRSP) Investor Presentation - Slideshow

    2:28 p.m. Nov. 23, 2021

    - Seeking Alpha

  7. CRISPR's Life-Saving Technology Has Massive Potential

    1:07 p.m. Nov. 22, 2021

    - Seeking Alpha

  8. Do CRISPR Therapeutics and Intellia Face a Big Safety Risk?

    11:31 a.m. Nov. 21, 2021

    - Motley Fool

  9. Better Buy: Vertex Pharmaceuticals vs. CRISPR

    7:00 a.m. Nov. 20, 2021

    - Motley Fool

  10. Loading more headlines...
/news/pressrelease/company/us/crsp

Press Releases on CRSP

  1. Loading more headlines...

Rates »

Link to MarketWatch's Slice.